Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Mutations Based on Next-Generation Sequencing May be Complementally to Prognostic Risk in Myelodysplastic Syndromes

Jing Wang, MD, Jinsong Jia, Xiaohong Liu, Lizhong Gong, Shengye Lu, Yu Wang, Lanping Xu, Xiaohui Zhang, Chenhua Yan, Yueyun Lai, Xiaosu Zhao, PhD, Yazhen Qin, Guorui Ruan, Yingjun Chang, Hongxia Shi, Kaiyan Liu, Xiaojun Huang, Hao Jiang, MD

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-140977

Published: 2020

Journal Articles

Both the Subtypes of Kit Mutation and Minimal Residual Disease Are Associated with Prognosis in Core Banding Factor Acute Myeloid Leukemia

Wenbing Duan, Xiaohong Liu, Jinsong JIA, MDPhD, Jing Wang, MD, Lizhong Gong, Qian Jiang, MD, Ting Zhao, Yu Wang, Xiaohui Zhang, Lanping Xu, Xiaosu Zhao, PhD, Yazhen Qin, Hongxia Shi, Yingjun Chang, Xiaojun Huang, Hao Jiang, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-141905

Published: 2020

Journal Articles

Determinants of Early Death and Outcomes for Acute Promyelocytic Leukemia in the Arsenic Era: A Real World Study

Honghu Zhu, Jinsong Jia, Jiang Qian, PhD, Hao Jiang, MD, Jin Lu, Bin Jiang, Xiaojun Huang

Blood (2017) 130 (Supplement 1): 1340.

https://doi.org/10.1182/blood.V130.Suppl_1.1340.1340

Published: 2017

Journal Articles

Mutation Topology of Adult B-Cell Acute Lymphoblastic Leukaemia

Li-Xin Wu, Run-Qing Lu, Kai-Yan Liu, Robert Peter Gale, MD ScD, PhD, Qi Zheng, Jiao Zhou, Jin-Lan Li, Shu-Juan Wang, Hao Jiang, MD, Qian Jiang, MD, Bin Jiang, Xiao-Hui Zhang, MD, Lan-Ping Xu, Yue Wang, Cheng-Li Song, Ya-Zhen Qin, Yan-Rong Liu, Xiao-Jun Huang, MD, Guo-Rui Ruan

Blood (2017) 130 (Supplement 1): 3986.

https://doi.org/10.1182/blood.V130.Suppl_1.3986.3986

Published: 2017

Journal Articles

Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Aclarubicin in MDS-EB and AML-MRC

Jing Liu, MD PhD, Jinsong Jia, MD, Li-Zhong Gong, MD, Shen-ye Lu, MD, Hong-Hu Zhu, MD, Xiao-Jun Huang, MD, Hao Jiang, MD

Blood (2017) 130 (Supplement 1): 2980.

https://doi.org/10.1182/blood.V130.Suppl_1.2980.2980

Published: 2017

Journal Articles

Clinical Features and Early Effect in EVI1 Positive Acute Myeloid Lleukemia

Wenbing Duan, Lizhong Gong, Jinsong Jia, Honghu Zhu, MD, Xiaosu Zhao, Qian Jiang, PhD, Ting Zhao, Ya-Zhen Qin, Xiaojun Huang, MD, Hao Jiang, MD

Blood (2017) 130 (Supplement 1): 5026.

https://doi.org/10.1182/blood.V130.Suppl_1.5026.5026

Published: 2017

Journal Articles

Complete Responses of Myeloid/Lymphoid Neoplasms with Rearrangement of Pdgfra Presenting As AML/ALL/Myeloid Sarcoma to Imatinib Monotherapy

Rui MA, Jinsong Jia, MD, Jun Kong, MD, Xiaojun Huang, Hao Jiang, MD

Blood (2017) 130 (Supplement 1): 5027.

https://doi.org/10.1182/blood.V130.Suppl_1.5027.5027

Published: 2017

Journal Articles

Corticosteroids Plus Intravenous Immunoglobulin Compared with Corticosteroids for the Treatment of Immune Thrombocytopenia in Pregnancy: An Observational Multicenter Study in China

Xiao-Lu Zhu, Jing-Wen Wang, Jian-Liang Shen, Hui Liu, Ru Feng, Cheng-Hong Yin, Ying-Jun Chang, Jiang Qian, PhD, Hao Jiang, MD, Jin Lu, Mei-Ying Liang, Xiao-Hong Zhang, Jian-Liu Wang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, MD, Xiao-Hui Zhang, MD

Blood (2017) 130 (Supplement 1): 1039.

https://doi.org/10.1182/blood.V130.Suppl_1.1039.1039

Published: 2017

Journal Articles

Janus Kinase Inhibition By Ruxolitinib Combined with Nilotinib Has Superior Anti-Leukemia Propagating Cells Effect in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Yuan Kong, MD PhD, Yi-Lin Wu, Yang Song, Min-Min Shi, Ya-Zhen Qin, Yue-Yun Lai, Hao Jiang, MD, Qian Jiang, Xiao-Jun Huang

Blood (2016) 128 (22): 4023.

https://doi.org/10.1182/blood.V128.22.4023.4023

Published: 2016

Journal Articles

C-KIT- Mutated t(8;21)AML Patients with >3log Reduction of MRD Conferred a Very High Relapse and Need HSCT to Improve Outcome

Hong-Hu Zhu, Ya-Zhen Qin, Lan-Ping Xu, Qian Jiang, MD, Xiao-Hui Zhang, Hao Jiang, MD, Xiao-Jun Huang

Blood (2016) 128 (22): 1620.

https://doi.org/10.1182/blood.V128.22.1620.1620

Published: 2016

Journal Articles

The Initial Level of MLL-PTD Affects the Prognosis of Patients with Acute Myeloid Leukemia

Jun Kong, MD, Hao Jiang, MD, Yazhen Qin, Xiaosu Zhao, Dr., Hong-Hu Zhu, MD, Jinsong Jia, MD, Qian Jiang, MD, Jing Wang, MD, Ting Zhao, Xiao-Jun Huang

Blood (2016) 128 (22): 5241.

https://doi.org/10.1182/blood.V128.22.5241.5241

Published: 2016

Journal Articles

Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: To Allogeneic Stem Cell Transplantation or Not? a Single Center Experience

xiao-Jun Huang, MD, Jing Wang, MD, Qian Jiang, MD, Huan Chen, Lanping Xu, Xiao-Hui Zhang, Ya-Zhen Qin, Hao Jiang, MD, Jin Lu, Kai-Yan Liu, Bin Jiang

Blood (2016) 128 (22): 2308.

https://doi.org/10.1182/blood.V128.22.2308.2308

Published: 2016

Journal Articles

Risk-Stratification Treatment Directed by Minimal Residual Disease Improves the Outcome of Acute Myeloid Leukemia with t(8;21) in First Complete Remission: Results of the AML05 Multicentre Trial

Honghu Zhu, PhD, Xiao-hui Zhang, MD, PhD, Yazhen Qin, Hao Jiang, MD, Dai-Hong Liu, MD, PhD, Huan Chen, Qian Jiang, MD, Jun-Yue Chai, Li-Ru Wang, Xiaojun Huang

Blood (2012) 120 (21): 139.

https://doi.org/10.1182/blood.V120.21.139.139

Published: 2012

Journal Articles

CD58-Negtive Leukemia Initiating Cells Are Independently Associated with High Risk of Relapse in B-Precursor Acute Lymphoblastic Leukemia: A Comprehensive Clinical and Biological Profiling Study

Yuan Kong, MD, PhD, Yanrong Liu, MD, Honghu Zhu, PhD, Qian Jiang, MD, Hao Jiang, MD, Lan-Ping Xu, MD, Dai-Hong Liu, MD, PhD, Guo-Rui Ruan, PhD, Bin Jiang, MD, Kaiyan Liu, MD, Xiao-jun Huang, MD, PhD

Blood (2012) 120 (21): 1397.

https://doi.org/10.1182/blood.V120.21.1397.1397

Published: 2012

Journal Articles

Superiority of Haploidentical Related Hematopoietic Stem-Cell Transplantation Over Chemotherapy Alone for Patients with Intermediate- or Poor- Risk Acute Myeloid Leukemia in First Complete Remission,

Yingjun Chang, Honghu Zhu, Lanping Xu, Hao Jiang, MD, Daihong Liu, Qian Jiang, Kaiyan Liu, MD, PhD, Jin Lu, MD, Bin Jiang, Xiaojun Huang

Blood (2011) 118 (21): 4161.

https://doi.org/10.1182/blood.V118.21.4161.4161

Published: 2011

Journal Articles

Comparison of Response Over 6 Years Between Patients with Chronic Myeloid Leukemia Who Received Imatinib as Initial Therapy and Those Who Received Imatinib as Secondary Therapy.

Hao Jiang, MD, Xiaojun Huang, MD, PhD, Shanshan Chen, MD, Bin Jiang, Qian Jiang, PhD, Yazhen Qin, Yueyun Lai

Blood (2009) 114 (22): 4281.

https://doi.org/10.1182/blood.V114.22.4281.4281

Published: 2009

NARROW

Mutations Based on Next-Generation Sequencing May be Complementally to Prognostic Risk in Myelodysplastic Syndromes

Both the Subtypes of Kit Mutation and Minimal Residual Disease Are Associated with Prognosis in Core Banding Factor Acute Myeloid Leukemia

Determinants of Early Death and Outcomes for Acute Promyelocytic Leukemia in the Arsenic Era: A Real World Study

Mutation Topology of Adult B-Cell Acute Lymphoblastic Leukaemia

Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Aclarubicin in MDS-EB and AML-MRC

Clinical Features and Early Effect in EVI1 Positive Acute Myeloid Lleukemia

Complete Responses of Myeloid/Lymphoid Neoplasms with Rearrangement of Pdgfra Presenting As AML/ALL/Myeloid Sarcoma to Imatinib Monotherapy

Corticosteroids Plus Intravenous Immunoglobulin Compared with Corticosteroids for the Treatment of Immune Thrombocytopenia in Pregnancy: An Observational Multicenter Study in China

Janus Kinase Inhibition By Ruxolitinib Combined with Nilotinib Has Superior Anti-Leukemia Propagating Cells Effect in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

C-KIT- Mutated t(8;21)AML Patients with >3log Reduction of MRD Conferred a Very High Relapse and Need HSCT to Improve Outcome

The Initial Level of MLL-PTD Affects the Prognosis of Patients with Acute Myeloid Leukemia

Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: To Allogeneic Stem Cell Transplantation or Not? a Single Center Experience

Risk-Stratification Treatment Directed by Minimal Residual Disease Improves the Outcome of Acute Myeloid Leukemia with t(8;21) in First Complete Remission: Results of the AML05 Multicentre Trial

CD58-Negtive Leukemia Initiating Cells Are Independently Associated with High Risk of Relapse in B-Precursor Acute Lymphoblastic Leukemia: A Comprehensive Clinical and Biological Profiling Study

Superiority of Haploidentical Related Hematopoietic Stem-Cell Transplantation Over Chemotherapy Alone for Patients with Intermediate- or Poor- Risk Acute Myeloid Leukemia in First Complete Remission,

Comparison of Response Over 6 Years Between Patients with Chronic Myeloid Leukemia Who Received Imatinib as Initial Therapy and Those Who Received Imatinib as Secondary Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only